The largest database of trusted experimental protocols

Pgl4.42 luc2p hre hygro vector

Manufactured by Promega
Sourced in United States

The PGL4.42 (luc2P/HRE/Hygro) vector is a plasmid designed for the expression of the luciferase reporter gene luc2P under the control of a hypoxia response element (HRE) promoter. It also includes a hygromycin resistance gene for selection purposes.

Automatically generated - may contain errors

3 protocols using pgl4.42 luc2p hre hygro vector

1

Luciferase Reporter Assays for STAT3, HIF-1, and NF-κB

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase assays were performed as described previously74 (link). In accordance with the manufacturer’s instructions, Cignal Reporter Assay Kit STAT3 (QIAGEN, Hilden, Germany) was used as a STAT3 reporter plasmid. The HIF-1 reporter plasmid [pGL4.42 (luc2P/HRE/Hygro) vector] was purchased from Promega (Madison, WI, USA), and the NF-κB reporter plasmid used in this study was described73 (link). Forty-eight hours after transfection, reporter activity was assessed by GLOWMAX (Promega) with the Dual-luciferase reporter assay system (Promega).
+ Open protocol
+ Expand
2

Hypoxia-Induced Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All obtained transduced variants of 1BR.3.N cells were cotransfected using FUGENE HD transfection reagent (Promega Corporation, Madison, WI, USA) with 1 μg of pGL4.42 [luc2P/HRE/Hygro] vector (Promega Corporation, Madison, WI, USA) together with 0.1 μg of pGL4.75 Renilla luciferase reporter vector (Promega Corporation, Madison, WI, USA), used as a normalization control. Transfection was performed according to the manufacturer’s instruction. The cells were afterwards cultured at standard condition (5% CO2; 37 °C) for 24 h. Then, the transfection’s medium were removed and 75 µL of the medium was added: to the first one 5mM glucose concentration and 25 mM to the other. One of the plates was then incubated for 6h under hypoxia conditions (1% O2) and the next under normoxic conditions (19% O2). After incubation, the luciferase activity in each group was measured using the Dual-Glo Luciferase Assay System (Promega Corporation, Madison, WI, USA) by the VICTOR Multilabel plate reader (PerkinElmer, Waltham, MA, USA).
+ Open protocol
+ Expand
3

ASCL1 Binding Sites in IGFBP5 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
To explore the potential ASCL1 binding sites in the IGFBP5 gene, fragments of IGFBP5 that are upstream and downstream of the genomic transcription start site were amplified and subcloned into the pGL4.42 (luc2P/HRE/Hygro) vector (Promega) using the XhoI and KpnI sites. Ten reporter vectors were generated with this strategy, pGL4.P1 (P1, −1.5 kb ∼−50 bp), pGL4.P2 (P2, −0.6 kb ∼−50 bp), pGL4.P3 (P3, +0.1 kb ∼+0.9 kb), pGL4.P4 (P4, +2.9 kb ∼+3.2 kb), pGL4.P5 (P5, +3.2 kb ~+3.5 kb), pGL4.P6 (P6, +6 kb ~+6.6 kb), pGL4.P7 (P7, +6.6 kb ~+7 kb), pGL4.P8 (P8, +7.2 kb ~+7.9 kb), pGL4.P9 (P9, +7.9 kb ~+8.4 kb) and pGL4.P10 (P10, +9 kb ~+10 kb). The E-box-deficient pGL4.42 mutants reporters were generated using the QuikChange site-directed mutagenesis kit (Stratagene). The sequences of the primers are listed in Supplementary Table 3. To perform the luciferase reporter assay, these pGL4 reporter vectors were co-transfected with pLenti-V5-ASCL1, pLenti-V5-NEUROD1 or pLenti-V5-GFP into HEK293T cells. The pGL4–hRluc expressing the Renilla reniformis luciferase under the TK promoter was used as the internal control in each experiment. Forty eight hours after transfection, cells lysates were collected and were used to determine the luciferase activity using the protocol from Promega. Experiments were performed in triplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!